Dow Up 0.25% Nasdaq Up 0.65%

AbbVie Inc. (ABBV)

-NYSE
62.71 Up 0.81(1.31%) May 27, 4:02PM EDT
|After Hours : 62.71 0.00 (0.00%) May 27, 5:07PM EDT
Prev Close:61.90
Open:61.99
Bid:62.21 x 1100
Ask:62.65 x 100
1y Target Est:71.06
Beta:1.42761
Earnings Date:Jul 22 - Jul 26 (Est.)
Day's Range:61.90 - 63.20
52wk Range:45.45 - 71.60
Volume:5,768,006
Avg Vol (3m):7,622,830
Market Cap:101.44B
P/E (ttm):18.85
EPS (ttm):3.33
Div & Yield:2.28 (3.68%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.31%101.44B
PFEUp 0.52%209.90B
MRKUp 0.16%156.34B

Key Statistics

Forward P/E (1 yr):11.12
P/S (ttm):4.21
Ex-Dividend Date:13-Apr-16

Analysts

Annual EPS Est (Dec-16) :4.76
Quarterly EPS Est (Jun-16) :1.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):0.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback